The goal of therapeutic cooling is slowing the body's metabolism and preventing brain damage or death. It is believed that mild therapeutic hypothermia suppresses harmful chemical reactions in the brain and preserves cells. Two key studies published in 2002 found therapeutic hypothermia more effective for sudden cardiac arrest patients than traditional therapies.
Mayo researchers analyzed a database covering more than 1 million patients and found mortality rates among in-hospital sudden cardiac arrest patients dropped from 69.6 percent in 2001 -- the year before the studies appeared -- to 57.8 percent in 2009, the most recent data available.
"Because we reviewed such a large number of cases, we are confident that the reduction in mortality among in-hospital sudden cardiac arrest patients is significant and sustained," says co-author Alejandro Rabinstein, M.D., a Mayo Clinic neurologist. "We continue to seek answers to the questions: Why did this trend develop, and how can we accelerate it," says co-author Jennifer Fugate, D.O.
These measures are important because disease accumulates in the cortex over time, and inflammation in the cortex is a sign the disease has progressed.
Other studies being presented at AAN:
Structured resident sign-out during shift changes improves patient care: In the study, junior residents in Mayo Clinic's General Neurology, Stroke and Neurologic Intensive Care Units spent the first half of their rotations using unstructured sign-out approaches and transitioned to a structured system for the second half. The residents reported that the standardized sign-out improved communication substantially, including information on pertinent past medical history, pending lab tests, recommendations on how to handle nursing and pharmacy calls, and up-to-date code status. Residents using standardized sign-out were also more likely to share test results with patients and their families prior to shift changes. This led to a significant increase in overall satisfaction with the sign-out process.
"This study is particularly timely now, when residency programs are adjusting to new duty-hour restrictions established in 2010," says lead author Brian Moseley, M.D., a Mayo Clinic neurology resident and Assistant Professor of Neurology. "When you have hand-offs because of the duty restrictions, unless the communication is good, there is a lot of opportunity for error," says Jeffrey Britton, M.D., a Mayo Clinic neurologist and study co-author. "This structured method seems to both prevent the error, but also make the patient and their family feel comfortable that this important communication is happening," says Dr. Britton.Medical costs rise significantly as patients move from normal cognition through mild cognitive impairment to full-blown dementia:
"Data about medical costs across the full range of cognitive decline are essential for identifying cost-effective strategies to postpone and prevent the onset of Alzheimer's disease," says co-author Cynthia Leibson, Ph.D., a Mayo Clinic epidemiologist. "Building on these data, we next will consider nursing home costs associated with dementia and identify the risk factors that underlie the differences between individual patients and among cognitive categories."
Stroke prevention program helps patients reduce risk factors:
Patients in a stroke prevention program were likelier to follow a prescribed diet and exercise than those receiving traditional care, Mayo researchers found in a study supported by the American Heart Association. Sixty-one percent of patients in the physician-directed, nurse-based program reduced at least one major risk factor after one year, such as high blood pressure, diabetes, smoking or high blood cholesterol. Just 33 percent of patients receiving more traditional care improved over the same period. The patients studied had suffered an atherosclerotis stroke -- a stroke caused by a blocked blood vessel leading to or within the brain -- and were at high risk for a second stroke.
"The study shows that relatively modest changes to a traditional care model for chronic disease can make a major difference in the continued health of stroke patients," says co-author Kelly Flemming, M.D., a Mayo Clinic neurologist.
JOURNALISTS: Mayo Clinic experts will be available to reporters seeking comment on research presented at AAN. Please contact Brian Kilen at above contact info.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.org/about/ and www.mayoclinic.org/news
Brian Kilen | EurekAlert!
How to design city streets more fairly
18.05.2020 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH
Insects: Largest study to date confirms declines on land, but finds recoveries in freshwater – Highly variable trends
24.04.2020 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig
Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major...
In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.
Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...
An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...
Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.
Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
05.06.2020 | Life Sciences
05.06.2020 | Physics and Astronomy
05.06.2020 | Life Sciences